Woodline Partners LP grew its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.6% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 763,472 shares of the company's stock after purchasing an additional 26,648 shares during the quarter. Cardinal Health comprises about 0.7% of Woodline Partners LP's portfolio, making the stock its 14th biggest holding. Woodline Partners LP owned about 0.32% of Cardinal Health worth $105,184,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. Principal Financial Group Inc. increased its position in shares of Cardinal Health by 5.3% during the 1st quarter. Principal Financial Group Inc. now owns 315,817 shares of the company's stock worth $43,510,000 after purchasing an additional 15,956 shares during the last quarter. Kingswood Wealth Advisors LLC increased its position in shares of Cardinal Health by 17.2% during the 1st quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company's stock worth $429,000 after purchasing an additional 457 shares during the last quarter. Assenagon Asset Management S.A. increased its position in shares of Cardinal Health by 25.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company's stock worth $1,811,000 after purchasing an additional 2,694 shares during the last quarter. Golden State Wealth Management LLC lifted its position in shares of Cardinal Health by 569.5% in the first quarter. Golden State Wealth Management LLC now owns 395 shares of the company's stock valued at $54,000 after buying an additional 336 shares during the last quarter. Finally, North Capital Inc. acquired a new stake in shares of Cardinal Health in the first quarter valued at approximately $83,000. Institutional investors and hedge funds own 87.17% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on CAH shares. Bank of America raised their price objective on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, June 10th. Robert W. Baird raised their price objective on Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research report on Wednesday, August 13th. Evercore ISI cut their target price on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a research note on Wednesday, August 13th. Wells Fargo & Company restated an "overweight" rating and set a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Finally, Argus set a $189.00 target price on Cardinal Health in a research report on Friday, August 22nd. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $165.93.
Get Our Latest Stock Report on Cardinal Health
Cardinal Health Price Performance
CAH traded down $0.14 during trading on Friday, hitting $152.34. 1,162,569 shares of the stock traded hands, compared to its average volume of 2,399,280. Cardinal Health, Inc. has a twelve month low of $106.54 and a twelve month high of $168.44. The company has a market cap of $36.38 billion, a price-to-earnings ratio of 23.62, a PEG ratio of 1.26 and a beta of 0.73. The business has a 50 day moving average price of $154.75 and a 200 day moving average price of $147.48.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company's revenue was up .5% on a year-over-year basis. During the same period in the previous year, the business earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio is currently 31.63%.
Insider Buying and Selling at Cardinal Health
In related news, insider Ola M. Snow sold 28,151 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. This represents a 64.59% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the sale, the insider owned 48,457 shares of the company's stock, valued at $7,211,370.74. The trade was a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock worth $40,489,525 over the last 90 days. 0.09% of the stock is owned by corporate insiders.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report